Medifast [MED] vs Medirom Healthcare [MRM] Detailed Stock Comparison

Medifast Inc.

NYSE
Loading...

Medirom Healthcare Technologies Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Medifast Inc. wins in 6 metrics, Medirom Healthcare Technologies Inc. wins in 11 metrics, with 0 ties. Medirom Healthcare Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medifast Inc. Medirom Healthcare Technologies Inc. Better
P/E Ratio (TTM) 531.50 3.09 Medirom Healthcare Technologies Inc.
Price-to-Book Ratio 0.57 5.92 Medifast Inc.
Debt-to-Equity Ratio 5.38 786.42 Medifast Inc.
PEG Ratio -0.22 N/A N/A
EV/EBITDA -1,469.18 27.84 Medirom Healthcare Technologies Inc.
Profit Margin (TTM) -4.84% 0.50% Medirom Healthcare Technologies Inc.
Operating Margin (TTM) -10.39% -25.84% Medifast Inc.
Return on Equity -9.13% 53.19% Medirom Healthcare Technologies Inc.
Return on Assets (TTM) -3.34% -1.78% Medirom Healthcare Technologies Inc.
Free Cash Flow (TTM) $1.25M $-1.90B Medifast Inc.
1-Year Return -10.95% -26.45% Medifast Inc.
Price-to-Sales Ratio (TTM) 0.32 0.00 Medirom Healthcare Technologies Inc.
Enterprise Value $-42.61M $25.99M Medirom Healthcare Technologies Inc.
EV/Revenue Ratio -0.11 0.51 Medirom Healthcare Technologies Inc.
Gross Profit Margin (TTM) 69.43% N/A N/A
Revenue per Share (TTM) $35 $1,222 Medirom Healthcare Technologies Inc.
Earnings per Share (Diluted) $-1.70 $0.37 Medirom Healthcare Technologies Inc.
Beta (Stock Volatility) 0.56 1.07 Medifast Inc.
Short % of Float 19.31% 1.55% Medirom Healthcare Technologies Inc.

Medifast Inc. vs Medirom Healthcare Technologies Inc. Stock Performance Analysis

Loading Price Chart...

MED
MRM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medifast Inc.0.25%-6.69%15.43%14.57%12.98%17.98%
Medirom Healthcare Technologies Inc.0.00%-0.83%-2.46%-9.16%-44.13%-39.29%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medifast Inc.-10.95%-85.01%-95.99%-61.95%-51.02%-36.36%
Medirom Healthcare Technologies Inc.-26.45%-81.00%-89.30%-92.08%-92.08%-92.08%

Performance & Financial Health Analysis: Medifast Inc. vs Medirom Healthcare Technologies Inc.

MetricMEDMRM
Market Information
Market Cap i$121.13M$9.25M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i240,38733,787
90 Day Avg. Volume i275,59225,639
Last Close$12.27$1.19
52 Week Range$9.22 - $15.46$0.90 - $4.45
% from 52W High-20.63%-73.26%
All-Time High$336.99 (May 24, 2021)$19.80 (Dec 28, 2020)
% from All-Time High-96.36%-93.99%
Growth Metrics
Quarterly Revenue Growth-0.37%-0.07%
Quarterly Earnings Growth-0.37%N/A
Financial Health
Profit Margin (TTM) i-0.05%0.01%
Operating Margin (TTM) i-0.10%-0.26%
Return on Equity (TTM) i-0.09%0.53%
Debt to Equity (MRQ) i5.38786.42
Cash & Liquidity
Book Value per Share (MRQ)$19.29$0.19
Cash per Share (MRQ)$16.22$4.13
Operating Cash Flow (TTM) i$6.86M$-5,623,917
Levered Free Cash Flow (TTM) i$5.41M$1.96M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Medifast Inc. vs Medirom Healthcare Technologies Inc.

MetricMED (Apr 24, 2026)MRM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i531.503.09
Forward P/E i-4.00N/A
PEG Ratio i-0.22N/A
Price to Sales (TTM) i0.320.00
Price to Book (MRQ) i0.575.92
Market Capitalization
Market Capitalization i$121.13M$9.25M
Enterprise Value i$-42,606,284$25.99M
Enterprise Value Metrics
Enterprise to Revenue i-0.110.51
Enterprise to EBITDA i-1,469.1827.84
Risk & Other Metrics
Beta i0.561.07
Book Value per Share (MRQ) i$19.29$0.19

Financial Statements Comparison: Medifast Inc. vs Medirom Healthcare Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMED (2025)MRM (2024)
Revenue/Sales i385.79M8.30B
Cost of Goods Sold i110.60M6.05B
COGS % of Revenue i28.7%72.9%
Gross Profit i275.19M2.25B
Gross Margin i71.3%27.1%
Research & Development iN/AN/A
Operating Income (EBIT) i-14.21M18.63M
Operating Margin i-3.7%0.2%
EBITDA i29,000351.61M
EBITDA Margin i0.0%4.2%
Pre-Tax Income i-5.64M47.71M
Pre-Tax Income % of Revenue i-1.5%0.6%
Income Tax i13.03M-90.48M
Income Tax % of Revenue i3.4%-1.1%
Net Income (Profit) i-18.67M138.19M
Profit Margin i-4.8%1.7%

Balance Sheet & Liquidity Metrics

MetricMED (2025)MRM (2024)
Cash & Equivalents i89.30M329.40M
Total Current Assets i201.68M2.71B
Total Current Assets % of Revenue i52.3%32.6%
Total Current Liabilities i42.96M4.18B
Total Current Liabilities % of Revenue i11.1%50.4%
Long-Term Debt iN/A2.05B
Long-Term Debt % of Revenue i0.0%24.7%
Total Shareholders Equity i198.92M1.19B
Retained Earnings i158.27M229.04M
Retained Earnings % of Revenue i41.0%2.8%
Property, Plant & Equipment i7.23M2.07B

Cash Flow Statement Comparison

MetricMED (2025)MRM (2024)
Operating Cash Flow i8.92M1.28B
Operating Cash Flow % of Revenue i2.3%15.4%
Capital Expenditures i-5.61M-71.41M
Free Cash Flow i1.25M-1.90B
FCF Margin i0.3%-22.9%
Debt Repayment iN/A-685.04M
Common Stock Repurchase i-369,000N/A

Short Interest & Institutional Ownership Analysis

MetricMEDMRM
Shares Short i2.06M101,129
Short Ratio i7.142.00
Short % of Float i19.31%1.55%
Shares Outstanding i10.99M7.90M
Float Shares i8.48M5.82M
% Held by Insiders i3.86%26.42%
% Held by Institutions i78.14%0.18%
% Held by Public i18.00%73.40%

Dividend Analysis & Yield Comparison: Medifast Inc. vs Medirom Healthcare Technologies Inc.

MetricMEDMRM
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$2.74N/A
3-Year Avg Dividend Yield i1.43%N/A
3-Year Total Dividends i$8.22N/A
Ex-Dividend DateJun 26, 2023N/A